Indicate the alpha₁ adrenoreceptor antagonist, which improves urine flow and is used in benign prostatic hyperplasia:

Questions 263

ATI RN

ATI RN Test Bank

Pharmacology Across the Lifespan ATI Quizlet Questions

Question 1 of 5

Indicate the alpha₁ adrenoreceptor antagonist, which improves urine flow and is used in benign prostatic hyperplasia:

Correct Answer: C

Rationale: The correct answer is C) Tamsulosin. Tamsulosin is an alpha₁ adrenoreceptor antagonist that specifically targets the alpha₁ receptors in the smooth muscle of the bladder neck and prostate, leading to relaxation of these muscles. This action results in improved urine flow and is commonly used in the treatment of benign prostatic hyperplasia (BPH). A) Phentolamine is an alpha adrenergic antagonist, but it is not selective for the alpha₁ receptors targeted in BPH treatment. B) Prazosin is also an alpha₁ adrenoreceptor antagonist, but it is not commonly used in the treatment of BPH. It is more commonly used to treat hypertension. D) Tolazoline is an alpha adrenergic antagonist, but it is not typically used in the treatment of BPH. It has other indications such as in the management of persistent pulmonary hypertension in newborns. Understanding the different classes of alpha adrenoreceptor antagonists and their specific applications is crucial in pharmacology practice, especially when managing conditions like BPH. Knowing the mechanism of action of each drug allows healthcare providers to make informed decisions when selecting the most appropriate medication for a patient's condition.

Question 2 of 5

Beta-receptor blocking drugs are used in the treatment all of the following diseases EXCEPT:

Correct Answer: C

Rationale: In this scenario, the correct answer is C) Pheochromocytoma. Beta-receptor blocking drugs, also known as beta-blockers, are commonly used in the treatment of conditions such as hypertension, ischemic heart disease, and cardiac arrhythmias because they help reduce the workload on the heart and lower blood pressure. However, beta-blockers are contraindicated in conditions like pheochromocytoma, which is a rare tumor of the adrenal gland that causes excess release of catecholamines like adrenaline. Beta-blockers can worsen hypertension in patients with pheochromocytoma by blocking the beta-receptors that would normally help counteract the effects of excessive catecholamines. Option A) Hypertension, ischemic heart disease, cardiac arrhythmias is incorrect because beta-blockers are commonly used to treat these conditions due to their ability to reduce heart rate, blood pressure, and cardiac workload. Option B) Glaucoma is incorrect because beta-blockers can be used topically to lower intraocular pressure in the eye and are a common treatment for glaucoma. Option D) Hyperthyroidism is incorrect because beta-blockers can help manage symptoms of hyperthyroidism such as tachycardia and tremors by blocking some of the effects of excess thyroid hormone. In an educational context, understanding the appropriate use of medications like beta-blockers is crucial for nursing students to ensure safe and effective care for patients across the lifespan. It is important for students to grasp the contraindications and indications for medications to make informed clinical decisions and provide quality patient care. Additionally, recognizing the specific conditions where beta-blockers are contraindicated, like pheochromocytoma, highlights the importance of individualized patient care and the impact of pharmacological choices on patient outcomes.

Question 3 of 5

Which of the following hypnotic drugs binds selectively to the subtype of the GABA receptor, responsible for hypnotic action?

Correct Answer: A

Rationale: In this question, the correct answer is A) Zaleplon. Zaleplon binds selectively to the subtype of the GABA receptor responsible for hypnotic action. This means that Zaleplon specifically targets the receptors that induce sleep, making it an effective hypnotic drug. Now let's explore why the other options are incorrect: B) Diazepam is a benzodiazepine that acts on a broader range of GABA receptors, not selectively on the subtype responsible for hypnotic action. C) Phenobarbital is a barbiturate that also acts on multiple subtypes of GABA receptors, not specifically the ones involved in hypnotic effects. D) Chloral hydrate is a sedative-hypnotic drug that works through a different mechanism of action compared to GABA receptors. Educational context: Understanding the specific receptor subtypes targeted by different drugs is crucial in pharmacology to predict their effects and side effects accurately. Students must grasp these nuances to make informed decisions in clinical practice when selecting the most appropriate medication for a patient's condition.

Question 4 of 5

Indicate the hypnotic drug with the greatest margin of safety:

Correct Answer: B

Rationale: In this question, the correct answer is B) Zolpidem. Zolpidem is considered to have the greatest margin of safety among the options provided. This is because Zolpidem is a non-benzodiazepine sedative-hypnotic medication that is commonly used for the treatment of insomnia. It has a more selective action on the GABA receptors in the brain compared to other sedative-hypnotic drugs, leading to a lower risk of side effects and toxicity. Barbiturates (option A) have a narrow margin of safety and a high potential for overdose due to their significant central nervous system depressant effects. Chloral hydrate (option C) is an older sedative-hypnotic drug that has a narrow therapeutic window and can cause significant respiratory depression. Glutetemide (option D) is not a commonly used hypnotic drug and its safety profile is not as well established as Zolpidem. From an educational perspective, understanding the differences in the safety profiles of various hypnotic drugs is crucial for healthcare providers to make informed decisions when prescribing medications, especially in vulnerable populations like older adults. Emphasizing the importance of selecting medications with a wider margin of safety, such as Zolpidem in this case, can help prevent adverse drug reactions and improve patient outcomes.

Question 5 of 5

Toxic doses of hypnotics may cause a circulatory collapse as a result of:

Correct Answer: C

Rationale: In the context of pharmacology, understanding the effects of toxic doses of hypnotics on the body is crucial for safe and effective patient care. In this question, the correct answer is C) Action on the medullar vasomotor center. Hypnotics act on the central nervous system to induce sleep and can also depress other CNS functions. When toxic doses are administered, these drugs can have profound effects on vital functions, including cardiovascular regulation. The medullar vasomotor center is responsible for controlling blood vessel constriction and dilation, which in turn regulates blood pressure. In the case of toxic doses of hypnotics, their action on the medullar vasomotor center can lead to a disruption in the normal regulation of blood pressure, potentially causing circulatory collapse. This can result in a dangerous drop in blood pressure and compromised circulation to vital organs. Now, let's discuss why the other options are incorrect: A) Blocking alpha adrenergic receptors: While blocking these receptors can lead to vasodilation and a drop in blood pressure, it is not the primary mechanism through which toxic doses of hypnotics cause circulatory collapse. B) Increasing vagal tone: Increasing vagal tone would primarily affect heart rate and cardiac function, rather than directly causing circulatory collapse as described in the question. D) All of the above: While the effects described in options A and B can contribute to cardiovascular effects, the primary mechanism in this scenario is the action on the medullar vasomotor center. This educational context highlights the importance of understanding the specific mechanisms of action of medications, particularly in terms of potential adverse effects when administered in toxic doses. It underscores the need for healthcare providers to be vigilant in monitoring patients receiving hypnotics and to be prepared to manage potential cardiovascular complications that may arise.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions